Bureaucratic red tape, licence raj came down under Modi govt: SII chairman

Chairman of vaccine maker Serum Institute of India (SII), Dr Cyrus Poonawalla, on Friday hailed the Modi government saying that red-tapism and licence raj have come down under its rule.

Cyrus Poonawalla
Cyrus Poonawalla. Photo: ANI
Press Trust of India Pune
3 min read Last Updated : Aug 13 2021 | 4:11 PM IST

Recalling how the industry used to face "hardships" in securing permissions and "harassment from bureaucrats" 50 years ago, chairman of the city-based vaccine maker Serum Institute of India (SII), Dr Cyrus Poonawalla, on Friday hailed the Modi government saying that red-tapism and licence raj have come down under its rule.

He also said that in the past, he had to "fall at the feet" of bureaucrats and drug controllers in order to get permissions, and added that the situation has changed now, which resulted in quick launch of SII's COVID-19 vaccine - Covishield.

Poonawalla was speaking at the event where he received the Lokmanyat Tilak National Award instituted by the Lokmanya Tilak Trust here.

"Serum Institute was founded in 1966 the morning after my marriage with Villoo, my dear late wife, to whom I dedicate this award. Fifty years ago, the industry had to face hardships in getting basic facilities like power, water, in getting permissions from bureaucrats. It had to face harassment from bureaucrats...I was not supposed to say this," he said.

"Transport and communication were also great problems and challenges that were faced by my staff and fellow directors...It was a long journey and a very painful one, which has now become very rewarding. I had to fall at the feet of bureaucrats and drug controllers, etc, to get permissions. But I must stress that difficulties, red tape are much reduced now under the Modi government," he said.

 

Licence raj has also come down, which has resulted in quick launch of the coronavirus vaccine, Poonawalla said.

 

"Certainly, one of the major reasons why we could launch our vaccine so quickly was forthcoming grant or permission, encouragement to industries as the licence raj has come down considerably. We have got a drug controller, which responds in the evening even after the office hours. There is no need for 'maska polish' now," he said.

Taking about the award, he said that he values it a lot although he had been honoured in America, UK and various other countries in the past.

Speaking on the occasion, Deepak Tilak, president of the Lokmanya Tilak Trust, said, "In unstable and challenging conditions, SII took immense efforts to develop an indigenous vaccine, which mitigated panic associated with COVID-19. This is the result of the effort and solid support of Dr Cyrus Poonawalla to his team."

Former Union minister and senior Congress leader Sushil Kumar Shinde also lauded Poonawalla for his work and said that with the SII vaccine was saving lakhs of lives.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Serum Institute of IndiaNarendra ModiEase of Doing Businesslicence raj

First Published: Aug 13 2021 | 4:10 PM IST

Next Story